We examined 741 urinary tract isolates of the Morganella-Proteus-Providencia group, including the recently defined species Proteus penneri, for susceptibilities to aminoglycosides, semisynthetic penicillins, and cephalosporins. The data emphasize the importance of identification to the species level on the basis of marked species differences in patterns of susceptibility.
All of the organisms were isolated from urine specimens obtained from hospitalized patients with acute exacerbation of chronic urinary tract infection without urine flow obstruction but with underlying chronic pyelonephritis.
Only one isolate from a patient was tested to avoid multiple copies of the same strain.
Upon isolation or receipt, clinical isolates of Proteeae were fully identified and differentiated by standard procedures (2, 3, 5, 7, 8) .
All the strains were stored at -70°C, and fresh subcultures were used for susceptibility testing.
MICs were determined for each antimicrobial agent in liquid medium by using a Titertek Motorized Multidiluter and Automatic Inoculator (Flow Laboratories SpA, Milan, Italy). Serial twofold dilutions were prepared at concentrations ranging from 200 to 0.025 jig/ml. The microdilution wells were filled with 100-,ul samples of the antibiotic solution prepared in Mueller-Hinton broth (BBL Microbiology Systems, Cockeysville, Md.) except for aminoglycosides, for which the medium was supplemented with calcium and magnesium ions (10) .
The volume of the inoculum was 100 ,ul, with a final P. vulgaris, P. rettgeri, and P. alcalifaciens, in that order, were the most susceptible to amikacin. P. mirabilis showed susceptibility similar to that of P. stuartii, and P. penneri, for which MICs were similar to MICs for Morganella morganii, was the least susceptible. 
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P. mirabilis (including 28 P-lactamases producers) and P. and temocillin (P. vulgaris) and azlocillin, aztreonam, and imipenem (P. rettgeri).
Although only 39 P. penneri isolates were available for this study, they seemed to be markedly more resistant to all the penicillins tested than was P. vulgaris.
M. morganii strains had a susceptibility pattern very similar to that of the P. penneri strains.
Among the Proteeae studied, a remarkable difference in activity was noted for one P. penneri strain, which required up to 100 ,ug of ceftazidime or ceftriaxone per ml to be inhibited but was susceptible to 0.78 ,ug of imipenem per ml. This resistant P. penneri strain was obtained from a patient who had been treated with ceftriaxone. This was a woman with chronic interstitial nephritis and vesicoureteral reflux from whom a ceftriaxone-susceptible strain of P. penneri (MIC, 0.78 ,ug/ml) was isolated in pure culture (>105 CFU/ml) from a urine specimen before antimicrobial treatment. The patient received ceftriaxone at an intramuscular dose of 1 g every 24 h for 7 days and showed a prompt clinical response, but at 10 days posttherapy she relapsed with a recurrence of her urinary tract infection. From a urine specimen obtained at this time, a pure growth of >105 CFU of P. penneri per ml was again obtained, and this strain was found to be resistant to ceftriaxone and the other cephalosporins, with MICs increasing eightfold for ceftriaxone and ceftazidime, over fivefold for cefuroxime, and twofold for cefoxitin.
Serotyping conducted in our laboratory strongly suggested that the susceptible and resistant isolates were the same strain.
Major differences in susceptibilities to aminoglycosides, carbenicillinlike ,3-lactam antibiotics, and cephalosporins among Morganella-Proteus-Providencia group bacteria were demonstrated in this study. P. alcalifaciens and P. mirabilis were readily distinguishable by their marked susceptibilities to aminoglycosides and cephalosporins. P. stuartii was found to be typically resistant to tobramycin, whereas P. alcalifaciens was susceptible; furthermore, our data proved that Providencia spp. are susceptible to amikacin. In addition, marked differences between the susceptibilities of these three species to cephalosporins are reported here, and we found that these differences extend to all the modified penicillins that were tested in this study.
Interestingly, P. penneri was more resistant to the modified penicillins than was P. vulgaris. This behavior was consistent with previously reported antimicrobial susceptibilities to carbenicillin (4, 5) . Moreover, the higher resistance of P. penneri to cefuroxime clearly separated it from the other six species.
It is noteworthy that among the 39 P. penneri strains isolated in the Abruzzo region, one strain, derived from a patient who failed clinically during treatment with ceftriaxone, was resistant to broad-spectrum cephalosporins.
The emergence of such mutants, reported in vitro and in vivo by several researchers, especially in Enterobacter and Pseudomonas spp. (1, 13, 16) , was most probably due to the derepression of the inducible cephalosporinase during constitutive synthesis (14) . Overproduced P-lactamase acts by hydrolyzing the cephalosporins or by merely trapping them, thereby creating an enzymatic impenetrability of the cephalosporins into the periplasmic space of bacterial cells (15) .
In the present study, imipenem proved to be the most potent compound against P. penneri strains with derepressed 13-lactamase and thus seemed to be unaffected by the derepression of chromosomal P-lactamases, a statement also made by Sanders (12) .
With regard again to P. penneri, it is remarkable that this heretofore unknown species, isolated with some frequency in various laboratories, must be considered, although it is difficult to accept that it would not have been detected as an atypical indole-negative P. vulgaris strain or an atypical ornithine decarboxylase-negative P. mirabilis strain. It is likely that it has been isolated just as frequently before and was overlooked or misidentified.
In conclusion, the results of this in vitro study authorize us to affirm, in agreement with Hawkey et al. (4) , that accurate identification to the species level of isolates of Proteeae in surveys of susceptibilities to antimicrobial agents is essential if potentially misleading results are not to be reported. This work was supported by grant 86.01619.52 from the Consiglio Nazionale delle Ricerche (Italy).
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